Abstract:Introduction: Frailty is a well-defined clinical syndrome in humans caused by accumulation of impairments which result in loss of reserve capacity and increased vulnerability to disability, dependence, and death. Dogs are of particular interest in studies of frailty due to the similarities they share with people in their environment, lifestyles, and age-related diseases. Materials and methods: The aim of this study was to develop a frailty phenotype screening tool, based on previously validated measures in dogs, which could be easily applied in the clinical setting, and which was predictive of all-cause, short term (6-month) mortality. The study was conducted in two phases. In phase 1, a retrospective cohort of 51 dogs was used to identify and evaluate potential measures for the five domains of frailty. This information was then used to develop a simple frailty phenotype based on examination findings and owner directed questions. In phase 2 of the study, this phenotype was evaluated in a prospective cohort of 198 dogs aged 9 years or older from multiple different specialty and primary care services to determine how the phenotype performed across a diverse canine population. Results: The developed frailty phenotype was predictive of all-cause, short-term mortality independent of age, sex, or weight (hazard ratio = 4.71; 95% CI, 2.66-8.8). Of the covariates evaluated only breed was significant, with purebred dogs having 1.85 times higher mortality than mixed breed dogs (95% CI, 1.04-3.31). The frailty phenotype performed similarly across all hospital services from which patients were enrolled. Conclusion: Based on these findings, the defined frailty phenotype represents a valuable screening tool for early risk identification and intervention, and can aid in clinical decision making for owners and veterinarians. Additionally, it will promote further research into the understanding and treatment of frailty in dogs.

The companion dog as a model for human aging and mortality

The first comorbidity networks in companion dogs in the Dog Aging Project

The companion dog as a model for inflammaging: a cross-sectional pilot study

A biological age based on common clinical markers predicts health trajectory and mortality risk in dogs

Longevity of companion dog breeds: those at risk from early death

Healthy, Active Aging for People and Dogs

Aging at scale: Younger dogs and larger breeds from the Dog Aging Project show accelerated epigenetic aging.

Mapping the canine microbiome: Insights from the Dog Aging Project

Once-daily feeding is associated with better health in companion dogs: results from the Dog Aging Project

Dog size and patterns of disease history across the canine age spectrum: Results from the Dog Aging Project

Characterizing dog cognitive aging using spontaneous problem-solving measures: development of a battery of tests from the Dog Aging Project

Age-correlated changes in the canine oral microbiome

Transcriptomic and intervention evidence reveals domestic dogs as a promising model for anti-inflammatory investigation

The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review

Establishing a clinically applicable frailty phenotype screening tool for aging dogs

Co-analysis of methylation platforms for signatures of biological aging in the domestic dog reveals previously unexplored confounding factors

The effect of body size and inbreeding on cancer mortality in breeds of the domestic dog: a test of the multi-stage model of carcinogenesis

Animal companionship and psycho-social well-being: Findings from a national study of community-dwelling aging Canadians

Protein catabolites as blood-based biomarkers of aging physiology: Findings from the Dog Aging Project

How can we achieve more accurate reporting of average dog lifespan?

Model Organisms: Grandeur in the Diversity of Aging Organisms